Headquarters
Canada
Every company in the roster headquartered in Canada.
Research
Compare company financial metrics
Research adds sourced market cap, cash, runway and annualized R&D figures with metric-specific sorting.
Views
7 of 7 companies
| Company | Pipeline | Most advanced | Next readout |
|---|---|---|---|
 Bausch HealthBHC · NYSE | 14 assets: 13 approved, 1 Ph 2 | amiselimodPhase 2 · Ulcerative ColitisReliable signal | Dec 2028brodalumab · Approved |
 Lexaria BioscienceLEXX · Nasdaq | 2 assets: 2 Ph 1 | DehydraTECH-CBD/semaglutidePhase 1 · ObesityPartial signal | None on record |
 35PharmaPrivate | 1 asset: 1 Ph 2 | HS235Phase 1/2 · Hypertension | Mar 2028HS235 · Phase 1/2 |
 ConjuChemPrivate | 1 asset: 1 Ph 3 | CJC-1134-PCPhase 3 · Type 2 DiabetesPartial signal | None on record |
 Inversago PharmaPrivate | 1 asset: 1 Ph 2 | INV-202Phase 2 · ObesityPartial signal | None on record |
 ProMIS Neurosciences, Inc.PMN · Nasdaq | 1 asset: 1 Ph 1 | PMN310Phase 1 · Alzheimer's Disease | Dec 2026PMN310 · Phase 1 |
 Thryv TherapeuticsPrivate | 1 asset: 1 Ph 3 | THRV-1268Phase 2/3 · Heart FailurePartial signal | 30 Jun 2027THRV-1268 · Phase 2/3 |
Next readout: the earliest estimated primary completion of a trial the company or a partner on the asset runs (ClinicalTrials.gov).